Skip to main content

Table 1 Characteristics of the subjects with normal glucose tolerance (NGT) or diabetes mellitus (DM)

From: Adiponectin complexes composition in Japanese-Brazilians regarding their glucose tolerance status

  NGT (n = 27) DM (n = 26) P value
Age (years) 54.0 ± 9.2 55.3 ± 8.6 0.58a
BMI(kg/m2) 23.4 ± 2.4 25.1 ± 2.4 0.015a
Waist circumference (cm) 79.4 ± 6.5 85.1 ± 7.6 0.005a
Waist-hip ratio 0.83 ± 0.05 0.88 ± 0.07 0.005a
Total cholesterol (mg/dL) 200.9 ± 39.3 209.7 ± 33.4 0.384a
HDL-Cholesterol (mg/dL) 48.8 ± 14.1 48.1 ± 8.4 0.809a
LDL-cholesterol (mg/dL) 121.7 ± 39.1 126.4 ± 33.3 0.638a
Triglycerides (mg/dL) 132.0 (97.2-171.5) 227.5 (160.0-380.0) 0.001b
Fasting plasma glucose (mg/dL) 104.0 (100.2-107.7) 134.5 (127.0-170.0) <0.001b
Fasting plasma insulin (uU/mL) 5.8 ± 2.7 9.4 ± 3.3 <0.001a
HOMA-IR 1.39 (0.96-1.75) 3.01 (2.63-3.83) <0.001b
eGFR (mL/min/1.73 m2) 98.1 ± 37.3 97.8 ± 32.8 0.97a
HbA1C (%) - 6.2 (5.7-7.1) -
Treatment for diabetes (n)   
SU - 2 -
MTF - 1 -
SU + MTF - 1 -
SU + INS - 1 -
Treatment for hypertension (n)   
B- blocker 1 - -
Diuretic 1 1 -
ACEi 1 1 -
B-blocker + diuretic 1 1 -
Treatment for dyslipidemia (n)   
fibrate - 1 -
  1. Data are presented as mean ± SD, median (interquartile range) or n.
  2. SU: sulfonylrea; MTF: metformin; INS: insulin; ACEi: angiotensin-converting enzyme inhibitor;
  3. a t-test.
  4. b Mann–Whitney test.